Papers
1
Total Citations
4
H-Index
1
About
Dr. Zhong Tu is a distinguished urologic oncologist whose research focuses on optimizing surgical outcomes for bladder cancer patients, particularly through comparative effectiveness studies of minimally invasive versus open surgical approaches. His landmark multicenter study, "Survival after radical cystectomy for bladder cancer: Multicenter comparison between minimally invasive and open approaches" (2020), represents a pivotal contribution to evidence-based urologic oncology. This work, conducted through the Chinese Bladder Cancer Consortium (CBCC) across 13 major centers, systematically evaluated oncological outcomes in patients undergoing radical cystectomy, providing crucial real-world data on the comparative efficacy of minimally invasive and open surgical techniques. Despite its recent publication, the study has already garnered significant attention with 4 citations, reflecting its growing influence in shaping clinical decision-making. Dr. Tu's research addresses a critical gap in urologic oncology by offering rigorous, multicenter evidence that helps surgeons and patients weigh the trade-offs between surgical approaches. His collaborative work through the CBCC demonstrates a commitment to large-scale, multi-institutional research that advances the standard of care for bladder cancer patients.
Research Focus
Key Achievements
Top Papers
- 1